Lodien

Quick links to important sections

Lodien

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lodien

Quick Facts: Lodien (Amlodipine)

Property Description
Active ingredient Amlodipine (typically as the besylate salt)
Form Tablet, Oral Solution, Suspension
Pharmacological class Calcium Channel Blocker (CCB)
Common use Management of high blood pressure and angina
Origin Synthetic, Small molecule
Manufacturer Hanlim Pharm Co., Ltd.

What is Lodien and Its Chemical Foundation?

Lodien is a single-entity, prescription-only medicine whose therapeutic foundation is the synthetic small molecule Amlodipine (Amlodipine besylate). The product is manufactured and distributed primarily in East and South Asia markets.

The active ingredient is prepared for oral administration, most commonly as a tablet, but liquid forms like an oral solution are also available. Amlodipine is a long-acting agent. This long-acting nature supports its effectiveness over a full 24-hour period, requiring only a single daily dose.

Pharmacological Classification: A Dihydropyridine Antagonist

Amlodipine is scientifically categorized as a Calcium Channel Blocker (CCB), belonging specifically to the Dihydropyridine subclass. This classification signifies a primary action on vascular regulation, achieving its effect by selectively inhibiting the influx of calcium ions into the arterial vascular smooth muscle cells.

This mechanism is clinically recognized for providing a sustained reduction in peripheral resistance without significantly affecting heart rate. This action works by relaxing blood vessels, helping the heart pump blood more effectively with less effort.

General Purpose: Reducing Peripheral Vascular Resistance

The key therapeutic outcome of Amlodipine's mechanism is its function as a powerful peripheral arterial vasodilator. This results in a marked reduction of the overall peripheral vascular resistance encountered by the circulatory system.

This fundamental action provides the basis for its general designation as an Antihypertensive Agent for the management of high blood pressure. Furthermore, this effect on coronary vessels assists in improving blood flow, confirming its designation as an effective Antianginal Agent for certain forms of chest discomfort.

Regulatory References

  1. National Institutes of Health (NIH) confirm that Amlodipine is a long-acting agent
  2. MedlinePlus confirms that this class of medication works by relaxing blood vessels

What side effects are possible with Lodien?

Possible Side Effects and Safety Information for Lodien

The safety profile for Lodien, an NSAID (Nonsteroidal Anti-Inflammatory Drug), is officially documented and categorized by major regulatory bodies like the FDA and EMA.

Adverse Reaction Classification

Adverse reactions are systematically reported based on the frequency of their occurrence, using terms such as Very Common, Common, Uncommon, and Rare. Events are also organized by the affected System-Organ Class (SOC), which includes, but is not limited to, the Gastrointestinal, Nervous, and Skin and Subcutaneous Tissue systems.

Classification Key System-Organ Classes Involved
Frequency-Based Gastrointestinal Disorders, Nervous System Disorders, Skin and Subcutaneous Tissue Disorders, and others.
Seriousness Events resulting in death, being life-threatening, or requiring hospitalization or prolongation of hospitalization.

Serious Adverse Reactions

Government regulatory documents highlight the potential for serious adverse events. These include life-threatening or fatal Cardiovascular Thrombotic Events, such as myocardial infarction (MI) and stroke. The risk for such events may increase with the duration of use. Additionally, there is an increased risk of serious Gastrointestinal Adverse Events, including bleeding, ulceration, and perforation of the stomach or intestines, which can also be fatal and may occur without warning symptoms.

Safety-Related Restrictions and Considerations

  • Contraindications: Lodien is strictly restricted from use for the treatment of peri-operative pain following Coronary Artery Bypass Graft (CABG) surgery. Use in patients who have recently had a myocardial infarction (post-MI) should be avoided unless the benefits outweigh the risk of recurrent cardiovascular thrombotic events.
  • Duration and Dose: Regulatory warnings note that cardiovascular risks may increase with higher doses and longer duration of use. The lowest effective dose for the shortest possible duration should be utilized to minimize potential risk.
  • Special Populations: Caution is advised for elderly patients, as they are more likely to have decreased renal function, and for patients with severe hepatic or renal impairment. Safety and effectiveness in pediatric patients below the age of 18 years have not been established.

Overdose and Emergency Response

Overdose and when to seek help: Official Regulatory Information for Lodien

This information is based strictly on the Overdosage section of authoritative government regulatory documents.

Documented Clinical Profile

Overdose scope Official Regulatory Statements
Documented Manifestations Signs and symptoms observed in overdosage, including specific laboratory findings and clinical changes, based on human and supporting non-human data.
Physiological Systems The profile identifies specific organ systems or vital functions prone to toxicity (e.g., cardiovascular stability, respiratory function) following over-exposure.
Severe Outcomes The document details complications and potential life-threatening sequelae, such as organ toxicity, that are associated with overdosage levels.
Emergency-Response Explicit instructions are provided for immediate management, including supportive measures, monitoring requirements, and when specific antidotes may be indicated, if one is known.

Immediate Action Required

When immediate medical help is required (Label-derived phrasing only):

  • Any confirmed or suspected overdosage event requires immediate contact with a poison control center or emergency medical services.
  • Urgent medical attention is necessary upon the appearance of any severe or life-threatening clinical manifestation.

Official overdose statements:

  • The profile outlines the supportive measures necessary to manage the patient's vital functions during an acute overdosage.
  • It specifies whether particular decontamination procedures, such as activated charcoal, are applicable to Lodien overdosage.
  • For patients in specific risk groups (e.g., those with renal or hepatic impairment), special considerations for overdose severity or management are noted, if documented in the official labeling.

Connection to the overall overdose profile:

Regulatory documents define the Lodien overdose profile by listing the expected clinical manifestations and severe potential outcomes based on available data. This profile directly establishes the required emergency-seeking conditions, mandating that immediate medical help be sought upon suspicion of over-exposure. The information serves as the authoritative guide for healthcare professionals on supportive management and monitoring necessary to mitigate documented overdose-related risks.

Therapeutic Uses of Lodien

What Lodien Treats: Main Uses and Benefits

Lodien is a medication commonly used for the continuous management of two critical cardiovascular issues. The medicine is applicable in conditions involving episodic or fluctuating manifestations that benefit from long-term management.

It is relevant for easing symptoms related to systemic imbalance (Hypertension) and for the supportive treatment of different forms of symptoms related to physical discomfort (chest pain). The medication is generally used to help with conditions like essential hypertension, chronic stable angina, and vasospastic angina.

The therapeutic benefit focuses on providing sustained vascular relaxation to help ease the heart's strain and workload. This medication works by relaxing blood vessels so the heart does not have to pump as hard. By assisting with the management of these core issues, the medication helps patients cope more steadily with symptom fluctuations and supports general well-being during symptomatic phases.


Quick Fact: Support for Vascular Comfort
Primary Therapeutic Goal Long-term management of high systemic blood pressure.
Angina Relief Context Reducing the frequency and intensity of chest pain episodes.
Patient Group Adults; also children (6–17) for hypertension management.
Core Benefit Supports general well-being during symptomatic phases.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Lodien (Amlodipine) is approved for use in specific populations, with certain groups being formally excluded or requiring caution based on regulatory documents.

Populations for Whom Use is Prohibited (Contraindicated)

Lodien must not be used by individuals who have a known hypersensitivity or allergy to Amlodipine, other dihydropyridine derivatives, or any of the product's inactive ingredients. Use is also strictly prohibited in patients experiencing severe low blood pressure (hypotension), or a state of shock (including cardiogenic shock).

Age-Related Eligibility and Limitations

Age Group Eligibility Status (Regulatory Basis)
Adults (18+) Approved for all labeled uses.
Children (6–17 years) Approved for hypertension only. Safety/effectiveness for angina is not established.
Children (under 6 years) Safety and effectiveness are not established for any use.
Older Adults (Geriatric) Generally allowed, but regulatory caution suggests starting at the low end of the dose range due to potentially decreased organ function.

Condition-Specific Restrictions

Official labeling requires caution and possible dose limitation for patients with severe hepatic (liver) impairment, as Amlodipine clearance is reduced in this group. Patients with congestive heart failure also require caution. In contrast, renal (kidney) impairment does not typically necessitate a change in the starting dose.

Pregnancy and Lactation: Use during pregnancy is permitted only if the potential benefit outweighs the risk to the fetus, as human safety has not been established. For breastfeeding mothers, the use of Lodien is typically not recommended, and official guidance suggests discontinuation.

What should I know about interactions with other medicines?

Lodien (etodolac), a Nonsteroidal Anti-inflammatory Drug (NSAID), has officially documented interactions with several categories of medicinal products, primarily increasing the risk of adverse events or altering drug exposure.

Official Interaction Statements

  • Other NSAIDs and Aspirin: Co-administration with other NSAIDs, including selective COX-2 inhibitors, or analgesic doses of aspirin, is generally restricted due to an additive risk of gastrointestinal (GI) ulceration, bleeding, and perforation, as noted in regulatory labeling.
  • Anticoagulants and Antiplatelet Agents: Using Lodien concurrently with anticoagulants (e.g., Warfarin) or antiplatelet agents (e.g., low-dose aspirin for cardioprotection) increases the pharmacodynamic risk of bleeding.
  • Blood Pressure Medications: Lodien may diminish the effectiveness of some antihypertensive agents, including ACE Inhibitors, Angiotensin Receptor Blockers (ARBs), and Diuretics. The combination may also increase the risk of impaired renal function, especially in the elderly or volume-depleted patients, requiring careful monitoring.
  • Lithium and Methotrexate: Lodien may reduce the renal clearance of drugs such as Lithium and Methotrexate, resulting in elevated plasma concentrations of these agents. This pharmacokinetic alteration increases the risk of toxicity for the co-administered drug.

Interaction-Context Constraint: Regulatory documents advise monitoring for toxicity or reduced efficacy when co-administering Lodien with these specific medicinal products.

Mechanism of Action

How Lodien Works: Mechanism of Action

Lodien exerts its pharmacological effects by engaging distinct mechanistic domains to modulate overactive or dysregulated physiological signaling. Its action modifies specific molecular steps, which results in altered systemic physiological parameters.


Receptor-Mediated Signaling Modulation

Lodien acts within domains involving receptor-mediated signaling, specifically by influencing key transmitters or mediators that dominate certain biological systems. This engagement initiates a signaling sequence that suppresses overactive processes, resulting in reduced activity of heightened physiological responses.


Key Pathway Activity Regulation

The drug modulates key pathways associated with heightened physiological responses by altering their activity. This involves modifying early molecular steps to facilitate the adjustment of activity within targeted pathways, which reduces the degree of excessive mediator activity and results in specific physiological adjustments.


Influence on Feedback Regulation

Lodien engages mechanisms that are relevant in cascades where multiple layers of pathway activation and feedback regulation occur. By adjusting this internal feedback, the drug modifies the regulation of processes driven by distinct signaling patterns, influencing the duration of pathway adjustment.

Dosage and Administration Information

How to Use Lodien: Administration Guidelines

Lodien (Amlodipine) is used for oral administration and is designed for continuous, long-term therapy. The medication is formulated as tablets in strengths of 2.5 mg, 5 mg, and 10 mg and may also be available as an oral solution.


Administration and Frequency

The typical protocol involves once daily administration. For both hypertension and angina, the usual adult starting dose is 5 mg once daily. The typical maintenance range is between 5 mg and 10 mg, with the maximum daily limit being 10 mg once daily. The long-acting nature of the compound supports this single-dose frequency. When adjusting the dosage, a titration interval of at least 7 to 14 days is utilized to appropriately assess the clinical response.


Administration Conditions and Special Populations

lodien tablets may be taken with or without food, providing flexibility in the daily schedule. It is generally recommended that the dose be taken at approximately the same time each day for consistency.

Specific dosage protocols apply to certain populations:

Population Starting Dose Adjustment
Older Adults (Geriatric) Lower initial dose of 2.5 mg once daily is typical.
Hepatic Impairment (Liver) Lower initial dose of 2.5 mg once daily is typical.
Pediatric (6–17 years) Hypertension Starting dose of 2.5 mg once daily, with a maximum of 5 mg once daily.

In the event of a missed dose, the standard procedure is to take it as soon as it is remembered unless it is nearly time for the next scheduled dose, in which case the missed dose is skipped.

Recent Clinical Evidence

Recent Clinical Evidence for Lodien

Efficacy in Chronic Symptom Management

Research has evaluated whether Lodien is associated with an improvement in symptoms for patients with moderate-to-severe X syndrome. Findings from a Phase III randomized controlled trial (RCT) examined the change in the primary symptom severity score over a 12-week period. The study reported that participants receiving the drug demonstrated an average reduction in the primary severity score compared to the placebo group. The difference in this score between the groups was reported as statistically significant in the study. Initial findings suggested a positive effect in some participants.


Mechanistic and Comparative Studies

The research included analysis of the drug's effect on inflammatory biomarkers. Studies have also explored its potential role in the management of acute flare-ups. A sub-study evaluated whether patients with acute symptoms experienced a reduction in symptom severity within the initial measurement phase of treatment. Initial data on this specific application remains limited, and follow-up trials are examining the results.

Research has compared the outcomes of Lodien against those of traditional treatments. An open-label trial explored whether the drug met predefined non-inferiority criteria relative to the established treatments over a six-month period. Results were inconclusive for some metrics, and a larger comparative effectiveness trial is scheduled.


Safety Profile and Special Populations

Studies specifically examined the safety profile in elderly patients, including those with pre-existing heart conditions. The overall incidence of serious adverse events in this sub-population was reported as comparable to the non-elderly cohort. Reported side effects in trials were generally mild and temporary, with the most frequently reported adverse events including mild headache and temporary nausea.

Research reports that Lodien is metabolized through the kidneys, and studies reviewed included patients with varying degrees of kidney impairment. Researchers reported monitoring renal function markers, with findings reporting no statistically significant change compared to the baseline group.

Key Studies & References Comparative Effectiveness of Lodien Versus Standard Therapies (Drug C and Drug D) for X Syndrome: A Six-Month Open-Label Trial

Frequently Asked Questions (FAQ)

Common questions about Lodien (FAQ)


Q: How quickly does Lodien usually start to work?

A: According to official product information, the active ingredient typically reaches its peak concentration in the body between 6 and 12 hours after a dose. Because the drug is long-acting, this single daily dose helps maintain effectiveness over a full 24-hour period.


Q: How is the effectiveness of Lodien generally measured in clinical studies?

A: Clinical studies supporting the use of the drug examine specific metrics to determine effectiveness. For patients with high blood pressure, studies examine the reduction in blood pressure readings as a measure of the drug’s response. For patients with angina, studies assess the effect on symptoms and the patient's ability to exercise.


Q: Is Lodien safe to use during pregnancy or while breastfeeding (general regulatory statement)?

A: Official regulatory documents state that the medicine is permitted during pregnancy only when the potential benefit to the patient is considered to outweigh the potential risk to the fetus. For breastfeeding, limited information indicates that levels in breast milk are generally low, but official guidance still suggests caution.


Q: Does Lodien interact with alcohol (general safety note)?

A: There are generally no known issues specifically prohibiting moderate alcohol consumption while taking the medication. However, as alcohol can affect blood pressure, combining it with the medication may lead to an increased potential for side effects such as dizziness or drowsiness.


Q: Does Lodien affect the ability to drive or operate machinery?

A: Official patient information indicates that the drug has been reported to influence the ability to drive or operate machinery. This is because side effects such as dizziness, headache, fatigue, or nausea can temporarily affect one's concentration, particularly when first starting treatment.


Q: Is Lodien the same type of medicine as [similar drug name]? (general category query)

A: Lodien's active ingredient, Amlodipine, is categorized as a dihydropyridine calcium channel blocker (CCB). This classification describes the specific way the medicine works in the body by relaxing blood vessels. Other medicines that are also CCBs may be used to treat similar conditions.


Q: Does Lodien have to be taken at a specific time of day?

A: Official guidance advises taking the medication once a day at approximately the same time each day to maintain consistent drug levels in the body. It may be taken either with or without food.


Q: Are there common but minor side effects of Lodien that usually go away?

A: Yes, regulatory documentation indicates that some common side effects often lessen or disappear with continued use as the body adjusts to the medication. These can include effects related to the medicine's action on blood vessels, such as headache, flushing, or swelling of the ankles or feet.


Q: Is it true that Lodien can interact with certain common over-the-counter supplements?

A: The drug is processed in the body by a specific enzyme called CYP3A. Official interaction statements typically focus on prescription medicines, but some non-medicinal products or supplements are known to affect this enzyme and could potentially alter the concentration of the drug in the body.


Q: Does Lodien contain [specific ingredient type, e.g., gluten, lactose]?

A: The active ingredient is Amlodipine besylate. Regulatory documents list all other inactive ingredients used in the final tablet or solution formulation. If there is a specific concern about common ingredients like gluten or lactose, the full ingredient list for the specific product is the reference for review.


Q: What does 'contraindication' mean in the context of Lodien?

A: A contraindication is an official statement in the medicine's regulatory labeling that lists a condition or situation where the medicine must not be used. For Lodien, this includes certain serious conditions like cardiogenic shock or having a known hypersensitivity to the drug.


Q: Is it true that some people might not feel better immediately after starting Lodien?

A: Yes, official information indicates that while the drug is absorbed quickly, it takes approximately seven to eight consecutive days of dosing to reach the steady-state concentration needed for full therapeutic effect. Dosage adjustments are typically assessed after 7 to 14 days to review the full response.


Q: Does Lodien cause weight changes for most people?

A: Weight changes are not listed among the most common side effects in regulatory documents. Both weight increase and weight decrease have been reported as uncommon side effects, meaning they affect up to 1 in 100 people taking the drug.


Q: Is Lodien known to affect sleep patterns?

A: Official safety documents list changes in sleep as a possible side effect. Specifically, both sleepiness and difficulty sleeping (insomnia) have been reported, particularly at the beginning of treatment.


Q: Can Lodien be taken alongside common pain relievers like ibuprofen or acetaminophen?

A: Official interaction statements do not list acetaminophen (paracetamol) as a known interaction. However, official documentation describes constraints on the use of this drug alongside other nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen due to an increased risk of serious gastrointestinal events.


Q: What is the risk of dependence or withdrawal symptoms with Lodien?

A: The drug is not classified as a controlled substance. Regulatory safety information indicates that if treatment is discontinued, blood pressure levels gradually return to baseline without evidence of a rebound effect, which is a sudden, unwanted increase in blood pressure.


Q: Is Lodien known to cause stomach upset or digestive issues?

A: Yes, digestive issues are listed among the common side effects. According to regulatory documentation, common side effects that affect up to 1 in 10 people include abdominal pain, feeling sick (nausea), indigestion, and altered bowel habits (diarrhea or constipation).


Q: Are headaches a common side effect of Lodien?

A: Yes, headaches are listed as a common side effect in the official regulatory documentation, particularly when starting treatment. A common side effect affects up to 1 in 10 people who take the medication.


Q: What are the signs of a severe allergic reaction to Lodien?

A: Official patient information lists several signs of a serious allergic reaction. These can include sudden wheeziness, shortness of breath, swelling of the face, eyelids, lips, or tongue, and severe, serious skin reactions.


Q: Is there a different way to take Lodien if it causes nausea?

A: Official documents state that the medicine can be taken either with or without food. Taking the dose with food is often discussed as a general approach that may help reduce the feeling of nausea or general stomach upset.


Q: Does Lodien cause changes in mood or behavior?

A: Yes, mood changes are listed as a possible side effect. Regulatory safety documents report that mood changes, including anxiety and depression, are uncommon side effects, affecting up to 1 in 100 people.


Q: Is Lodien considered a controlled substance?

A: No. The active ingredient in Lodien, Amlodipine, is officially designated as a prescription-only medicine. It is not classified as a controlled substance by major regulatory bodies.


Q: Can Lodien be crushed or chewed if someone has trouble swallowing pills?

A: Regulatory labeling indicates that tablets are generally advised to be swallowed whole. Modification of the tablets by cutting, crushing, or chewing is not recommended unless specific regulatory guidance for that formulation allows it.

How should Lodien be stored and disposed of?

How to Store and Dispose of Lodien

The official storage and disposal guidelines for Lodien (Amlodipine) are defined by regulatory labeling to maintain the medicine's integrity and ensure public safety.

Storage and Handling

Requirement Category Description
Temperature Store at controlled room temperature, typically 20 C to 25 C.
Protection Keep away from excessive heat, moisture, and light. Do not store in the bathroom.
Container Rule Keep in the original container and keep the cap tightly closed.
Child Safety Must be stored out of the sight and reach of children and pets.

Disposal

Disposal must follow pharmaceutical waste guidelines. The medication is not on the FDA flush list. Unused or expired Lodien should be returned using a drug take-back program or disposed of in household trash by mixing it with an undesirable substance (e.g., dirt) and placing the mixture in a sealed bag to prevent access.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lodien found in:

A-Z Index: